Member Info for Heimdal

The 10.6m South China buy order @ 15.9c was not hit - not executed..

The "Golden Finger" is back bignose ;-)

Did you see the 10,600,000 South China buy order @ 15.9c yesterday?

What is the market price of a HKSE shell nowadays? HK$400m - HK$700?

Hold fast fellas, plenty of news to look forward to within the next few weeks/months:

- Update on CBD development in China
- Confirmation of completion of FDA Phase II validation study
- New launches in Greece and Romania by Recordati
- New launches in Hong Kong and Macau by Orient EuroPharma
- ATO settlement
- Update from Wanbang on application for clinical trial approval in China
- Payment receipt of US$4,000,000 from Wanbang
- Maybe also some positive news on licensing agreement(s) for North America, India, Middle East and/or the LATAM region.

It is very positive that Recordati has re-launched Fortacin™ in France, Germany, Italy, Portugal, Spain and the UK - showing commitment. Indeed, as bignose pointed out, Fortacin is a world class product - just require brand awareness.
Hang in there guys. Fantastic opportunity to pick up a few more shares at these levels.

Heimdal

Regent Pacific Group Limited (the “Company”) announces that the board of directors of the Company (the “Board” or the “Directors”) has scheduled a meeting to be held on Friday, 23 August 2019 at 4:00 pm (Hong Kong time) for considering and approving the Company’s unaudited interim results for the six months ended 30 June 2019 and that the Company will make a preliminary announcement in respect of its interim results on that date.

VXR: Change in Substantial Holding https://www.asx.com.au/asxpdf/20190806/pdf/447884w03l4ysg.pdf

Shocking to see RPG trading @ 17.5c. Macquarie all over the sell side this morning. Will bounce

Sold down on very low vol, not pretty though

Indeed, with hq in KL these days

20.5c.. Unbelievable! I notice Kim Eng very active in the market on the sell side with a stack of minor orders.

Nonetheless, VXR up 10.3% this morning - $100m of debt funding now secured from Trafigura. This adds HKD4m to our holding which is currently valued at AUD8.17m or 86% of the outstanding ATO bill. VXR rerating on the cards. All major boxes ticked with full production within the next 24 months. 10 year mine life. Strong margins and cash flow. Significant upside. Happy to hold.

The Italian, WRT the ATO payment.. our current VXR holding is 13.55% with a value of AUD7.41m -
about 78% of the outstanding ATO payment. VXR in trading halt in relation to debt funding of the SS Project
in WA. Once funding resolved we should expect a sp increase. Full production within the next 24 months. Robust project.
News on CBD development in China and HK launch should not be far away. Keep the faith - sp will bounce.

Out now oldman :-)

"Regent CEO Jamie Gibson said he’s hopeful a final deal can be signed in the coming weeks and close shortly thereafter. Regent plans to start selling CBD through Yooya within 90 days of closing the acquisition." Whoa!

Thank you for sharing CI6. Very positive development indeed.

Sounds very promising indeed. Hopefully a masterstroke.

Dougie, <3 months ago (on August 24) the company confirmed that:‧ 本集團繼續就於二零一八年下半年於希臘、羅馬尼亞、捷克共和國、斯洛伐克 共和國和波蘭的FortacinTM已規劃在列的的商業化活動與Recordati緊密合作, 進行商業化活動以在未來幾年瞄準歐洲其他國家、俄羅斯、獨立國家聯合體（獨 聯體）和選定的北非國家。Heimdal.

That is indeed great news Italian, thanks for sharing. The significant announcement wrt roll-out of Fortacin™ in Greece, Romania, Czech Republic, Slovak Republic and Poland (combined population of 85M) is due any day now and I expect a higher impact on sp than the HK rego ann. Maybe we will revisit 77c soon? Chart looking good :-)
In terms of roll-out, how long did it actually take VIAGRA to gain traction on a global scale?

Chart gap filled - time to roll again. Another leg up. Heimdal

https://www.openpr.com/news/1352956/Premature-Ejaculation-Treatment-Market-Explore-Future-Growth-To-2026-Anticipated-by-Global-Top-Players-Regent-Pacific-Group-Limited-Menarini-Group-Furiex-Pharmaceuticals-Inc-Absorption-Pharmaceuticals-LLC-Ampio-Pharmaceuticals-Inc-Aytu-BioScie.html

Happy to be back on board, it should be onwards and upwards from here guys. Great product. Roll out in progress. Do not lose hope. Heimdal